FDA Approved: ZILXI — Original Application (Journey Medical Corporation)

View source ↗

Summary

FDA approved ZILXI (minocycline) from Journey Medical Corporation via an original NDA for the treatment of inflammatory lesions of rosacea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rosacea

Drugs mentioned

• ZILXI (minocycline)

Snippet

ORIG AP for ZILXI (MINOCYCLINE)